Entrada Therapeutics

Entrada Therapeutics TRDA Stock

$4.96   -0.799999%
Add to favorites
Market Cap
$194.19M
LOW - HIGH [24H]
$4.91 - $5.43
VOLUME [24H]
$432.58K
P/E Ratio
0
Earnings per share
-$3.84
ISIN
US29384C1080
Price   Prediction

Entrada Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Entrada Therapeutics (TRDA) stock price today is 4.96 USD on Tech Market Middle (-0.8% on the day). Updated .

Entrada Therapeutics TRDA Financial and Trading Overview

Entrada Therapeutics stock price 4.96 USD
Previous Close 5.09 USD
Open 5 USD
Bid 5.21 USD x 200
Ask 8.87 USD x 200
Day's Range 4.84 - 5.22 USD
52 Week Range 4.11 - 16.45 USD
Volume 607.03K USD
Avg. Volume 376.34K USD
Market Cap 195.75M USD
Beta (5Y Monthly) -0.154
PE Ratio (TTM) N/A
EPS (TTM) -3.84 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 18.75 USD

TRDA Valuation Measures

Enterprise Value 37.2M USD
Trailing P/E N/A
Forward P/E -1.4716703
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 49.22094
Price/Book (mrq) 0.92030185
Enterprise Value/Revenue 9.353
Enterprise Value/EBITDA -0.224

Trading Information

Entrada Therapeutics Stock Price History

Beta (5Y Monthly) -0.154
52-Week Change -39.90%
S&P500 52-Week Change 13.32%
52 Week High 16.45 USD
52 Week Low 4.11 USD
50-Day Moving Average 5.6 USD
200-Day Moving Average 8.46 USD

TRDA Share Statistics

Avg. Volume (3 month) 376.34K USD
Avg. Daily Volume (10-Days) 594.81K USD
Shares Outstanding 39.15M
Float 23.12M
Short Ratio 7.13
% Held by Insiders 13.76%
% Held by Institutions 84.30%
Shares Short 2.81M
Short % of Float 11.08%
Short % of Shares Outstanding 7.16%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) -4256.047%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -31.12%
Return on Equity (ttm) -59.87%

Income Statement

Revenue (ttm) 3.98M USD
Revenue Per Share (ttm) 0.1 USD
Quarterly Revenue Growth (yoy) -43.89%
Gross Profit (ttm) -129072000 USD
EBITDA -166060992 USD
Net Income Avi to Common (ttm) -161386000 USD
Diluted EPS (ttm) -3.76
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 193.02M USD
Total Cash Per Share (mrq) 5.29 USD
Total Debt (mrq) 47.31M USD
Total Debt/Equity (mrq) 23.86 USD
Current Ratio (mrq) 7.847
Book Value Per Share (mrq) 5.433

Cash Flow Statement

Operating Cash Flow (ttm) -136324992 USD
Levered Free Cash Flow (ttm) -80513376 USD

Profile of Entrada Therapeutics

Country United States
State MA
City Boston
Address One Design Center Place
ZIP 02210
Phone 857 520 9158
Website https://www.entradatx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 152

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Q&A For Entrada Therapeutics Stock

What is a current TRDA stock price?

Entrada Therapeutics TRDA stock price today per share is 4.96 USD.

How to purchase Entrada Therapeutics stock?

You can buy TRDA shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Entrada Therapeutics?

The stock symbol or ticker of Entrada Therapeutics is TRDA.

Which industry does the Entrada Therapeutics company belong to?

The Entrada Therapeutics industry is Biotechnology.

How many shares does Entrada Therapeutics have in circulation?

The max supply of Entrada Therapeutics shares is 39.15M.

What is Entrada Therapeutics Price to Earnings Ratio (PE Ratio)?

Entrada Therapeutics PE Ratio is now.

What was Entrada Therapeutics earnings per share over the trailing 12 months (TTM)?

Entrada Therapeutics EPS is -3.84 USD over the trailing 12 months.

Which sector does the Entrada Therapeutics company belong to?

The Entrada Therapeutics sector is Healthcare.

Entrada Therapeutics TRDA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24328.38 USD —
-0.74
8.59B USD — 23989.09 USD — 24547.66 USD — — 8.59B USD —
us US Tech Global Market Composite NQGM US 1835.7 USD —
-1.77
— — 1816.36 USD — 1866.76 USD — — — —
us US Tech Health Care IXHC US 1332.89 USD —
-0.73
— — 1323.81 USD — 1342.94 USD — — — —
$2.19T
Total marketcap
$72.09B
Total volume
BTC 59.06%   •   ETH 10.06%
Dominance
Select currency